Indivi
Indivi creates smartphone-based digital biomarkers to measure cognition, motion, vision, and voice for neurological disease drug development. The company builds validated, user-friendly digital measurement instruments and platforms (including Konectom and dreaMS) that combine smartphone sensors, signal processing, cloud software, and machine learning/AI to generate functional biomarkers and digital endpoints. It operates as a TechBio B2B SaaS and services provider to pharma, clinical research organizations, and academic groups, offering clinical trial protocol support, data collection, analysis, and regulatory reporting. Indivi is ISO 13485:2016 certified for SaMD manufacturing and collaborates with research centers and biopharma partners to support technical and regulatory adoption. Its tools are positioned to de-risk and accelerate neurodegenerative disease trials like Parkinson’s, multiple sclerosis, and Alzheimer’s.
Indivi
Indivi creates smartphone-based digital biomarkers to measure cognition, motion, vision, and voice for neurological disease drug development. The company builds validated, user-friendly digital measurement instruments and platforms (including Konectom and dreaMS) that combine smartphone sensors, signal processing, cloud software, and machine learning/AI to generate functional biomarkers and digital endpoints. It operates as a TechBio B2B SaaS and services provider to pharma, clinical research organizations, and academic groups, offering clinical trial protocol support, data collection, analysis, and regulatory reporting. Indivi is ISO 13485:2016 certified for SaMD manufacturing and collaborates with research centers and biopharma partners to support technical and regulatory adoption. Its tools are positioned to de-risk and accelerate neurodegenerative disease trials like Parkinson’s, multiple sclerosis, and Alzheimer’s.